Travere Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.0% | -9.9% | +15.4% | +4.0% | +4.6% | -8.9% | +7.6% | -1.5% | +7.5% | -9.6% | +13.0% | -0.7% | +5.2% | +2.3% | +1.4% | +5.6% | -0.3% | -7.0% | +15.2% | +24.9% | -16.1% | -15.3% | +11.7% | -48.2% | +99.0% | +2.0% | -43.5% | +15.2% | +21.5% | -8.2% | +30.8% | +16.2% | +18.9% | +9.3% | +40.0% | +44.0% | -21.3% | -1.9% | +33.3% | – | |
| – | -23.5% | -41.1% | +12.4% | +16.1% | +26.9% | +37.4% | -27.0% | -3.8% | +41.5% | -36.6% | -3.7% | +54.5% | +363.6% | -80.5% | +9.1% | -20.4% | +74.3% | -20.6% | +0.4% | -3.6% | +19.1% | +12.8% | -4.1% | +254.3% | -76.2% | +196.6% | -71.7% | -11.2% | +1,173.5% | -90.8% | +724.9% | -86.9% | +57.0% | +83.3% | -67.5% | +4.2% | +61.1% | +948.4% | -91.9% | – | |
| – | +11.6% | -8.9% | +15.5% | +3.7% | +4.0% | -10.2% | +9.1% | -1.5% | +6.6% | -8.6% | +13.4% | -2.0% | -7.4% | +17.0% | +1.2% | +6.4% | -2.1% | -6.4% | +15.7% | +25.8% | -16.9% | -16.3% | +12.4% | -60.1% | +160.2% | -4.2% | -40.7% | +16.5% | -20.0% | +39.2% | +4.6% | +46.9% | +17.9% | +6.7% | +46.6% | +44.6% | -22.1% | -21.0% | +66.7% | – | |
| – | +9.0% | +3.9% | -6.6% | +0.7% | -0.2% | +25.8% | +39.9% | -5.8% | -1.4% | +4.5% | +13.4% | -12.4% | +8.6% | -16.1% | +1.8% | +5.1% | +18.7% | +24.9% | +8.1% | -6.6% | +28.4% | -8.9% | +5.4% | -4.2% | +5.4% | -0.5% | +11.0% | -8.9% | -3.0% | +95.1% | -52.6% | -4.9% | +20.1% | -24.5% | +5.3% | +5.1% | +11.5% | -1.3% | +5.6% | – | |
| – | -8.4% | -13.2% | +24.7% | -13.8% | +9.7% | -3.0% | -5.2% | +4.0% | -0.6% | +25.9% | +19.3% | -23.6% | -7.5% | +20.4% | +5.5% | -8.6% | +11.9% | +0.0% | -2.2% | +3.1% | +16.7% | +32.8% | +3.6% | -9.4% | +20.0% | +4.8% | +3.4% | -0.6% | -6.2% | +1.0% | +0.9% | +1.3% | +5.9% | +4.8% | +4.6% | +13.4% | +17.6% | -21.1% | +19.8% | – | |
| – | -1.7% | -5.8% | +9.9% | -8.0% | +5.4% | +9.1% | +16.5% | -1.7% | -1.0% | +14.1% | +16.3% | -19.0% | -5.9% | +4.9% | +14.0% | -0.9% | +141.4% | -44.3% | -5.4% | +11.4% | +4.3% | +0.8% | +13.7% | -12.0% | +17.0% | +9.2% | +1.9% | -4.7% | -13.2% | +60.7% | -39.3% | +8.0% | +13.2% | -10.0% | +4.9% | +10.2% | +15.3% | -13.9% | +19.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -230.1% | – | – | – | |
| – | +50.5% | -70.7% | +398.5% | +0.3% | -49.5% | +7.5% | +195.3% | +139.6% | +100.0% | -3.9% | -1.0% | -5.6% | +1.1% | +6.3% | -5.2% | +2.9% | -0.1% | +11.7% | -8.8% | +1.0% | +3.5% | -50.4% | +18.2% | -4.8% | +2.4% | -1.6% | -0.2% | -0.8% | +0.0% | -0.7% | -0.4% | -0.4% | +1.4% | +1.4% | -0.4% | -3.3% | -16.5% | +0.2% | -7.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -181.9% | – | – | – | |
| – | -157.0% | – | – | – | – | -96.5% | -27.1% | +148.5% | -2,701.7% | – | -82.8% | -858.0% | – | -59,400.0% | – | -64.6% | -2,147.8% | – | -84.3% | -12.2% | -90.7% | +1,200.0% | +1.9% | +173.6% | -56.6% | +23.8% | -16.7% | -81.5% | +466.7% | +180.9% | -55.5% | -198.8% | – | – | -48.7% | -60.0% | +11,412.5% | -113.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,326.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | -159.8% | – | – | – | – | – | – | – | -89.4% | -1,459.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -1,337.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +972.3% | -101.4% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.